These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 29366993

  • 1. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation.
    Stojkovic S, Jurisic M, Kopp CW, Koppensteiner R, Huber K, Wojta J, Gremmel T.
    Atherosclerosis; 2018 Feb; 269():197-203. PubMed ID: 29366993
    [Abstract] [Full Text] [Related]

  • 2. Serum Cholinesterase Levels Are Associated With 2-Year Ischemic Outcomes After Angioplasty and Stenting for Peripheral Artery Disease.
    Gremmel T, Wadowski PP, Mueller M, Kopp CW, Koppensteiner R, Panzer S.
    J Endovasc Ther; 2016 Oct; 23(5):738-43. PubMed ID: 27328913
    [Abstract] [Full Text] [Related]

  • 3. Long-term Comparative Outcomes of Carotid Artery Stenting Following Previous Carotid Endarterectomy vs De Novo Lesions.
    Mousa AY, AbuRahma AF, Bozzay J, Broce M, Kali M, Yacoub M, Stone P, Bates MC.
    J Endovasc Ther; 2015 Jun; 22(3):449-56. PubMed ID: 25878023
    [Abstract] [Full Text] [Related]

  • 4. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center.
    Shammas NW, Shammas GA, Helou TJ, Voelliger CM, Mrad L, Jerin M.
    Cardiovasc Revasc Med; 2012 Jun; 13(4):224-7. PubMed ID: 22575073
    [Abstract] [Full Text] [Related]

  • 5. Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol.
    Soga Y, Iida O, Hirano K, Suzuki K, Yokoi H, Nobuyoshi M.
    Catheter Cardiovasc Interv; 2012 Mar 01; 79(4):541-8. PubMed ID: 21805619
    [Abstract] [Full Text] [Related]

  • 6. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K, Fujii K, Kawasaki D, Shibuya M, Fukunaga M, Imanaka T, Tamaru H, Sumiyoshi A, Nishimura M, Horimatsu T, Saita T, Okada K, Kimura T, Honda Y, Fitzgerald PJ, Masuyama T, Ishihara M.
    J Endovasc Ther; 2016 Jun 01; 23(3):424-32. PubMed ID: 27044270
    [Abstract] [Full Text] [Related]

  • 7. MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease.
    Zhu ZR, He Q, Wu WB, Chang GQ, Yao C, Zhao Y, Wang M, Wang SM.
    J Atheroscler Thromb; 2018 Nov 01; 25(11):1168-1181. PubMed ID: 29760303
    [Abstract] [Full Text] [Related]

  • 8. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
    Chan YC, Cheng SW, Cheung GC.
    J Vasc Surg; 2015 Nov 01; 62(5):1201-9. PubMed ID: 26169015
    [Abstract] [Full Text] [Related]

  • 9. Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case-control study.
    Pan CH, Chien SC, Chen CJ, Shih CM, Hsieh MH, Huang CY, Bi WF, Chan CS, Kao YT, Hsiao CY, Chiang SJ, Chiang KH, Huang JH, Liu YR, Luo JD, Huang HY, Wu CH.
    BMC Cardiovasc Disord; 2021 Feb 08; 21(1):77. PubMed ID: 33557763
    [Abstract] [Full Text] [Related]

  • 10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.
    Cardiovasc Revasc Med; 2009 Feb 08; 10(3):144-50. PubMed ID: 19595394
    [Abstract] [Full Text] [Related]

  • 11. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y, Soga Y, Iida O, Shiraki T, Kobayashi Y, Hiramori S, Ando K.
    J Endovasc Ther; 2016 Jun 08; 23(3):461-7. PubMed ID: 27004496
    [Abstract] [Full Text] [Related]

  • 12. Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease.
    Gremmel T, Koppensteiner R, Ay C, Panzer S.
    Eur J Clin Invest; 2014 Jun 08; 44(3):319-24. PubMed ID: 24382127
    [Abstract] [Full Text] [Related]

  • 13. Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease.
    Yang X, Lu X, Ye K, Li X, Qin J, Jiang M.
    Vasc Endovascular Surg; 2014 Jan 08; 48(1):18-26. PubMed ID: 24212407
    [Abstract] [Full Text] [Related]

  • 14. α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting.
    Lee S, Koppensteiner R, Kopp CW, Gremmel T.
    Sci Rep; 2019 Dec 03; 9(1):18200. PubMed ID: 31796860
    [Abstract] [Full Text] [Related]

  • 15. Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: a propensity-matched analysis.
    Kawamura Y, Ishii H, Aoyama T, Tanaka M, Takahashi H, Kumada Y, Toriyama T, Murohara T.
    J Vasc Surg; 2009 Nov 03; 50(5):1057-62. PubMed ID: 19782527
    [Abstract] [Full Text] [Related]

  • 16. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.
    Iida O, Takahara M, Soga Y, Nakano M, Yamauchi Y, Zen K, Kawasaki D, Nanto S, Yokoi H, Uematsu M, ZEPHYR Investigators.
    JACC Cardiovasc Interv; 2015 Jul 03; 8(8):1105-1112. PubMed ID: 26117463
    [Abstract] [Full Text] [Related]

  • 17. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: twelve-month results from a multicenter randomized trial.
    Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, Schroë H, Lansink W, Scheinert D, Schmidt A, Zeller T, Beschorner U, Noory E, Torsello G, Austermann M, Peeters P.
    J Endovasc Ther; 2015 Feb 03; 22(1):1-10. PubMed ID: 25775672
    [Abstract] [Full Text] [Related]

  • 18. German multicenter real-world registry of stenting for superficial femoral artery disease: clinical results and predictive factors for revascularization.
    Krankenberg H, Tübler T, Sixt S, Fischer M, Schmiedel R, Schulte KL, Balzer JO, Kieback A, Fiehn E, Wittenberg G, Ali T, Tiefenbacher C, Jahnke T, Steinkamp HJ, Wegscheider K, Treszl A, Ingwersen M, Zeller T.
    J Endovasc Ther; 2014 Aug 03; 21(4):463-71. PubMed ID: 25101571
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
    Kinstner CM, Lammer J, Willfort-Ehringer A, Matzek W, Gschwandtner M, Javor D, Funovics M, Schoder M, Koppensteiner R, Loewe C, Ristl R, Wolf F.
    JACC Cardiovasc Interv; 2016 Jul 11; 9(13):1386-92. PubMed ID: 27388828
    [Abstract] [Full Text] [Related]

  • 20. Interleukins and inflammatory markers in in-stent restenosis after femoral percutaneous transluminal angioplasty.
    Araújo PV, Ribeiro MS, Dalio MB, Rocha LA, Viaro F, Dellalibera Joviliano R, Piccinato CE, Évora PR, Joviliano EE.
    Ann Vasc Surg; 2015 Jul 11; 29(4):731-7. PubMed ID: 25725274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.